Viewing nowCombinationMahakan Tablet 16/5 mg
Candesartan Cilexetil 16mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.

MFDS item code 201603937 · Approved 2016.06.24 · Insurance code 640007020
Treatment of essential hypertension not controlled with monotherapy
Used for the treatment of essential hypertension that is not adequately controlled by monotherapy with Candesartan Cilexetil or Amlodipine.
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time every day (e.g., in the morning). It is recommended that the dose of each individual component (candesartan cilexetil or amlodipine) be adjusted before starting this medicine. However, if blood pressure is not controlled with monotherapy using either individual component, switching directly to this medicine may be considered as follows. - 8/5 mg: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 8 mg or amlodipine 5 mg. - 16/5 mg: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 16 mg or amlodipine 5 mg. - 16/10 mg: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 16 mg, amlodipine 10 mg, or this medicine 16/5 mg. Patients taking candesartan cilexetil and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. • Patients with renal impairment: Since an initial dose of candesartan cilexetil of 4 mg once daily is recommended for patients with renal impairment, it is not advisable to use this medicine as initial treatment. • Patients with hepatic impairment: Since an initial dose of candesartan cilexetil of 2 mg once daily is recommended for patients with mild or moderate hepatic impairment, it is not advisable to use this medicine as initial treatment.
• Children: Use of this medicine is not recommended in adolescents and children aged 18 years or younger because its safety and efficacy have not been established.
This medication can cause serious harm or death to the fetus and newborn if administered to pregnant women, so use should be discontinued immediately upon confirmation of pregnancy. Patients with hypersensitivity to this medication or certain conditions such as severe liver disease, severe kidney disease, or hereditary angioedema should not use this drug. Elderly patients, those with hyperkalemia, liver impairment, hypotension, heart valve disease, and kidney disorders should use this medication with caution. During the use of this medication, adverse reactions such as dizziness, headache, abdominal pain, fatigue, edema, and pruritus may occur, and if symptoms persist or worsen, consulting with a healthcare professional is advised. Especially for patients with impaired kidney function or heart failure, blood pressure, kidney function, and serum potassium levels should be regularly monitored. This medication may interact with other antihypertensives, diuretics, and potassium supplements; inform your doctor or pharmacist if you are taking other medications. Pregnant women or those planning to become pregnant are advised not to take this medication, and breastfeeding women should avoid its use or discontinue breastfeeding. The safety and efficacy of this medication in children and adolescents under the age of 18 years have not been established, and its use is not recommended in this population. In case of overdose, symptoms such as hypotension, dizziness, and tachycardia may appear, and immediate medical attention should be sought. Store this medication out of reach of children and do not transfer it to another container for safety. Caution is advised when driving or operating machinery, as dizziness or lethargy may occur.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a sealed container. The recommended storage temperature is room temperature between 1°C and 30°C.
Yellow, double-sided, convex, round film-coated tablet
30 tablets (10 tablets/ PTP × 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationCandesartan Cilexetil 16mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationCandesartan Cilexetil 16mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 16mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 8mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 8mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationCandesartan Cilexetil 16mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationCandesartan Cilexetil 8mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationCandesartan Cilexetil 16mg · Amlodipine Besylate 13.88mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.